5-amino-1mq nnmt inhibitor study Nicotinamide N-Methyltransferase in Cardiovascular Diseases: Metabolic Regulator and Emerging Therapeutic Target 5-Amino-1MQ

Appropriate use is determined individually by a licensed medical provider based on your health profile, and it requires a prescription and clinical oversight

Combined NNMT inhibitor treatment with reduced-calorie diet achieved 6.3 g cumulative weight loss versus 2.9 g with diet alone, and fat mass reduction was ten-fold greater with treatment (~29.3%) compared to diet switch alone (2.9%), while restoring fatty liver profiles to lean-control levels (Sampson et al., 2021)

Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant

5-Amino-1MQ Benefits: Comprehensive Metabolic Enhancement The 5 amino 1mq benefits extend far beyond simple weight reduction, encompassing comprehensive improvements in metabolic health, cellular function, and body composition

AOD 9604 has been evaluated in rodent models of obesity

For the beta diversity analyses, an analysis of similarities (ANOSIM) was performed on each of the distance/dissimilarity matrices to establish whether observed clustering by treatment group was statistically significant